Close

Valeant Pharma (VRX) Acquires Canadian Rights to Altace (SNY)

March 4, 2015 9:11 AM EST Send to a Friend
Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX), announced its acquisition of the Canadian rights for AltaceĀ® ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login